Drug Shortage Report for TOBRAMYCIN INJECTION USP
| Report ID | 193492 |
| Drug Identification Number | 02502372 |
| Brand name | TOBRAMYCIN INJECTION USP |
| Common or Proper name | TOBRAMYCIN INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 25 VIALS |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-29 |
| Estimated end date | 2023-06-16 |
| Actual end date | 2023-06-19 |
| Shortage status | Resolved |
| Updated date | 2023-06-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-06-20 | English | Compare |
| v4 | 2023-06-19 | French | Compare |
| v3 | 2023-06-19 | English | Compare |
| v2 | 2023-06-01 | French | Compare |
| v1 | 2023-06-01 | English | Compare |
Showing 1 to 5 of 5